Literature DB >> 27488522

Structural Basis for Induction of Peripheral Neuropathy by Microtubule-Targeting Cancer Drugs.

Jennifer A Smith1, Barbara S Slusher2, Krystyna M Wozniak3, Mohamed H Farah4, Gregoriy Smiyun1, Leslie Wilson5, Stuart Feinstein1, Mary Ann Jordan5.   

Abstract

Peripheral neuropathy is a serious, dose-limiting side effect of cancer treatment with microtubule-targeting drugs. Symptoms present in a "stocking-glove" distribution, with longest nerves affected most acutely, suggesting a length-dependent component to the toxicity. Axonal transport of ATP-producing mitochondria along neuronal microtubules from cell body to synapse is crucial to neuronal function. We compared the effects of the drugs paclitaxel and ixabepilone that bind along the lengths of microtubules and the drugs eribulin and vincristine that bind at microtubule ends, on mitochondrial trafficking in cultured human neuronal SK-N-SH cells and on axonal transport in mouse sciatic nerves. Antiproliferative concentrations of paclitaxel and ixabepilone significantly inhibited the anterograde transport velocity of mitochondria in neuronal cells, whereas eribulin and vincristine inhibited transport only at significantly higher concentrations. Confirming these observations, anterogradely transported amyloid precursor protein accumulated in ligated sciatic nerves of control and eribulin-treated mice, but not in paclitaxel-treated mice, indicating that paclitaxel inhibited anterograde axonal transport, whereas eribulin did not. Electron microscopy of sciatic nerves of paclitaxel-treated mice showed reduced organelle accumulation proximal to the ligation consistent with inhibition of anterograde (kinesin based) transport by paclitaxel. In contrast, none of the drugs significantly affected retrograde (dynein based) transport in neuronal cells or mouse nerves. Collectively, these results suggest that paclitaxel and ixabepilone, which bind along the lengths and stabilize microtubules, inhibit kinesin-based axonal transport, but not dynein-based transport, whereas the microtubule-destabilizing drugs, eribulin and vincristine, which bind preferentially to microtubule ends, have significantly less effect on all microtubule-based axonal transport. Cancer Res; 76(17); 5115-23. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27488522     DOI: 10.1158/0008-5472.CAN-15-3116

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Microtubule-Targeting Agents Eribulin and Paclitaxel Differentially Affect Neuronal Cell Bodies in Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Sarah J Benbow; Krystyna M Wozniak; Bridget Kulesh; April Savage; Barbara S Slusher; Bruce A Littlefield; Mary Ann Jordan; Leslie Wilson; Stuart C Feinstein
Journal:  Neurotox Res       Date:  2017-04-08       Impact factor: 3.911

2.  Anti-Inflammatory Properties of KLS-13019: a Novel GPR55 Antagonist for Dorsal Root Ganglion and Hippocampal Cultures.

Authors:  Douglas E Brenneman; William A Kinney; Mark E McDonnell; Pingei Zhao; Mary E Abood; Sara Jane Ward
Journal:  J Mol Neurosci       Date:  2022-07-02       Impact factor: 2.866

Review 3.  Building a Network of Adverse Outcome Pathways (AOPs) Incorporating the Tau-Driven AOP Toward Memory Loss (AOP429).

Authors:  Maria Tsamou; Erwin L Roggen
Journal:  J Alzheimers Dis Rep       Date:  2022-06-07

4.  Polyester Nanoparticle Encapsulation Mitigates Paclitaxel-Induced Peripheral Neuropathy.

Authors:  R Ganugula; M Deng; M Arora; H-L Pan; M N V Ravi Kumar
Journal:  ACS Chem Neurosci       Date:  2019-01-17       Impact factor: 4.418

Review 5.  Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems.

Authors:  Nathan P Staff; Jill C Fehrenbacher; Martial Caillaud; M Imad Damaj; Rosalind A Segal; Sandra Rieger
Journal:  Exp Neurol       Date:  2019-11-21       Impact factor: 5.330

6.  Comparative Analysis of Chemotherapy-Induced Peripheral Neuropathy in Bioengineered Sensory Nerve Tissue Distinguishes Mechanistic Differences in Early-Stage Vincristine-, Cisplatin-, and Paclitaxel-Induced Nerve Damage.

Authors:  Kevin J Pollard; Brad Bolon; Michael J Moore
Journal:  Toxicol Sci       Date:  2021-02-26       Impact factor: 4.849

Review 7.  Efficacy of eribulin in breast cancer: a short report on the emerging new data.

Authors:  Gelareh Eslamian; Caroline Wilson; Robin J Young
Journal:  Onco Targets Ther       Date:  2017-02-13       Impact factor: 4.147

8.  Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study.

Authors:  Junji Tsurutani; Yukinori Sakata; Toshiyuki Matsuoka
Journal:  Breast Cancer       Date:  2018-10-15       Impact factor: 4.239

9.  Human Induced Pluripotent Stem Cell Derived Sensory Neurons are Sensitive to the Neurotoxic Effects of Paclitaxel.

Authors:  Chenling Xiong; Katherina C Chua; Tore B Stage; Josefina Priotti; Jeffrey Kim; Anne Altman-Merino; Daniel Chan; Krishna Saraf; Amanda Canato Ferracini; Faranak Fattahi; Deanna L Kroetz
Journal:  Clin Transl Sci       Date:  2020-12-19       Impact factor: 4.689

Review 10.  Mini-Review: Mitochondrial dysfunction and chemotherapy-induced neuropathic pain.

Authors:  Timothy M Doyle; Daniela Salvemini
Journal:  Neurosci Lett       Date:  2021-06-26       Impact factor: 3.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.